Seth Meyers checks in on 'pharma bro' Martin Shkreli, finds he's just the tip of a price-gouging iceberg
Martin Shkreli, the widely despised former CEO of Turing Pharmaceuticals, infamous for raising the price of a life-saving drug by 5,000 percent, was called to testify before Congress last week. But instead of answering questions, Seth Meyers said on Tuesday's Late Night, "he spent the time doing what he does best: looking like a real slappable prick." Meyers illustrated his point with some footage of Shkreli invoking his Fifth Amendment right instead of answering even the most mundane questions.
As fun as it is to make fun of Shkreli, though, he's "not alone," Meyers said. "He's just doing what a lot of pharmaceutical companies already do, except he's being loud and conniving about it while they're being secretive and conniving about it." In fact, Shkreli is "just a convenient, deserving scapegoat" for the price-gouging of Americans by the drug industry, Meyers said, aided by Congress' decision to prevent the U.S. government from negotiating the price of drugs, like almost every other country does. Case in point, a company called Valeant bought two heart drugs just last year and immediately raised the price 525 percent and 212 percent, Meyers said, but "Valeant didn't cause nearly as much outrage as Shkreli did because they don't have a smug, irritating face; they have a soothing logo." Watch Meyers' "closer look" at Shkreli and the unsavory behavior he exposed below. Peter Weber
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Rupert Murdoch loses 'Succession' court battle
Speed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
By Peter Weber, The Week US Published
-
Bitcoin surges above $100k in post-election rally
Speed Read Investors are betting that the incoming Trump administration will embrace crypto
By Peter Weber, The Week US Published
-
Enron mystery: 'sick joke' or serious revival?
Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
By Peter Weber, The Week US Published
-
US charges Indian tycoon with bribery, fraud
Speed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
By Peter Weber, The Week US Published
-
Boeing machinists approve contract, end strike
Speed Read The company's largest union approved the new contract offer, ending a seven-week strike
By Peter Weber, The Week US Published
-
US economy still strong in final preelection report
Speed Read It grew at a solid 2.8% annual rate from July through September
By Peter Weber, The Week US Published
-
Boeing machinists reject deal, continue strike
Speed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
By Peter Weber, The Week US Published